• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迈向良好的体外报告标准。

Toward Good In Vitro Reporting Standards.

机构信息

Johns Hopkins Bloomberg School of Public Health, Center for Alternatives to Animal Testing (CAAT), Baltimore, MD, USA.

University of Konstanz, CAAT-Europe, Konstanz, Germany.

出版信息

ALTEX. 2019;36(1):3-17. doi: 10.14573/altex.1812191.

DOI:10.14573/altex.1812191
PMID:30633302
Abstract

A good experiment reported badly is worthless. Meaningful contributions to the body of science are made by sharing the full methodology and results so that they can be evaluated and reproduced by peers. Erroneous and incomplete reporting does not do justice to the resources spent on conducting the experiment and the time peers spend reading the article. In theory peer-review should ensure adequate reporting - in practice it does not. Many areas have developed reporting standards and checklists to support the adequate reporting of scientific efforts, but in vitro research still has no generally accepted criteria. It is characterized by a "Wild West" or "anything goes" attitude. Such a culture may undermine trust in the reproducibility of animal-free methods, and thus parallel the "reproducibility crisis" discussed for other life science fields. The increasing data retrieval needs of computational approaches (in extreme as "big data" and artificial intelligence) makes reporting quality even more important so that the scientific community can take full advantage of the results. The first priority of reporting standards is to ensure the completeness and transparency of information provided (data focus). The second tier is a quality of data display that makes information digestible and easy to grasp, compare and further analyze (information focus). This article summarizes a series of initiatives geared towards improving the quality of in vitro work and its reporting. This shall ultimately lead to Good In Vitro Reporting Standards (GIVReSt).

摘要

糟糕的实验报道是毫无价值的。只有分享完整的方法和结果,才能为科学领域做出有意义的贡献,让同行对其进行评估和重现。错误和不完整的报告是对用于进行实验的资源和同行阅读文章所花费的时间的不尊重。理论上,同行评审应该确保充分的报告,但实际上并非如此。许多领域已经制定了报告标准和清单,以支持科学工作的充分报告,但体外研究仍然没有普遍接受的标准。它的特点是“狂野西部”或“随心所欲”的态度。这种文化可能会破坏人们对无动物方法重现性的信任,从而与其他生命科学领域讨论的“可重复性危机”相呼应。计算方法(极端情况下为“大数据”和人工智能)的数据检索需求不断增加,使得报告质量变得更加重要,以便科学界能够充分利用研究结果。报告标准的首要任务是确保提供信息的完整性和透明度(数据重点)。其次是数据展示的质量,使信息易于理解、掌握、比较和进一步分析(信息重点)。本文总结了一系列旨在提高体外工作及其报告质量的举措。这最终将导致良好的体外报告标准(GIVReSt)。

相似文献

1
Toward Good In Vitro Reporting Standards.迈向良好的体外报告标准。
ALTEX. 2019;36(1):3-17. doi: 10.14573/altex.1812191.
2
Culture of Care: Organizational Responsibilities关怀文化:组织职责
3
The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement.《行为干预单病例报告指南(SCRIBE)2016声明》
J Clin Epidemiol. 2016 May;73:142-52. doi: 10.1016/j.jclinepi.2016.04.006. Epub 2016 Apr 19.
4
The Single-Case Reporting Guideline In Behavioural Interventions (SCRIBE) 2016 statement.《行为干预单病例报告指南(SCRIBE)2016声明》
Can J Occup Ther. 2016 Jun;83(3):184-95. doi: 10.1177/0008417416648124.
5
Minimum Information and Quality Standards for Conducting, Reporting, and Organizing In Vitro Research.进行、报告和组织体外研究的最低信息和质量标准
Handb Exp Pharmacol. 2020;257:177-196. doi: 10.1007/164_2019_284.
6
Improving transparency and scientific rigor in academic publishing.提高学术出版的透明度和科学性。
J Neurosci Res. 2019 Apr;97(4):377-390. doi: 10.1002/jnr.24340. Epub 2018 Dec 2.
7
Applying the STARD (Standards for Reporting of Diagnostic Accuracy) checklist to the 2007 Transfusion article 'Evaluation of a new enzyme-linked immunosorbent assay for detection of Chagas antibody in US blood donors'.将STARD(诊断准确性报告标准)清单应用于2007年输血领域的文章《一种用于检测美国献血者中恰加斯抗体的新型酶联免疫吸附测定法的评估》。
Trans R Soc Trop Med Hyg. 2008 Feb;102(2):155-60. doi: 10.1016/j.trstmh.2007.10.016. Epub 2007 Dec 20.
8
The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration.用于报告诊断准确性研究的STARD声明:解释与详述
Ann Intern Med. 2003 Jan 7;138(1):W1-12. doi: 10.7326/0003-4819-138-1-200301070-00012-w1.
9
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.
10
[Transparency and replicability of nursing intervention studies in long-term care: A selective literature review].长期护理中护理干预研究的透明度与可重复性:一项选择性文献综述
Z Evid Fortbild Qual Gesundhwes. 2018 May;133:1-8. doi: 10.1016/j.zefq.2017.11.006. Epub 2017 Dec 19.

引用本文的文献

1
Assessing risk of bias in toxicological studies in the era of artificial intelligence.评估人工智能时代毒理学研究中的偏倚风险。
Arch Toxicol. 2025 Aug;99(8):3065-3090. doi: 10.1007/s00204-025-03978-5.
2
Soft tissue attachment of human gingival fibroblasts to titanium dioxide nanotubes compared to commercially pure titanium and its alloys: a systematic review.与商业纯钛及其合金相比,人牙龈成纤维细胞在二氧化钛纳米管上的软组织附着:一项系统评价。
BDJ Open. 2025 Jun 18;11(1):58. doi: 10.1038/s41405-025-00293-0.
3
Identifying assessment criteria for in vitro studies: a method and item bank.
确定体外研究的评估标准:一种方法和项目库。
Toxicol Sci. 2024 Oct 1;201(2):240-253. doi: 10.1093/toxsci/kfae083.
4
Recommendations on fit-for-purpose criteria to establish quality management for microphysiological systems and for monitoring their reproducibility.关于建立微生理系统质量管理和监测其重现性的适用标准的建议。
Stem Cell Reports. 2024 May 14;19(5):604-617. doi: 10.1016/j.stemcr.2024.03.009. Epub 2024 Apr 25.
5
Towards in vitro models for reducing or replacing the use of animals in drug testing.致力于开发体外模型以减少或替代药物测试中动物的使用。
Nat Biomed Eng. 2024 Aug;8(8):930-935. doi: 10.1038/s41551-023-01154-7.
6
Taking the leap toward human-specific nonanimal methodologies: The need for harmonizing global policies for microphysiological systems.迈向人类特异性非动物方法学的飞跃:协调全球微生理系统政策的必要性。
Stem Cell Reports. 2024 Jan 9;19(1):37-40. doi: 10.1016/j.stemcr.2023.11.008. Epub 2023 Dec 21.
7
New approach methodologies in human regulatory toxicology - Not if, but how and when!人类监管毒理学中的新方法学——不是如果,而是如何以及何时!
Environ Int. 2023 Aug;178:108082. doi: 10.1016/j.envint.2023.108082. Epub 2023 Jul 4.
8
Systematic comparison of transcriptomes of Caco-2 cells cultured under different cellular and physiological conditions.在不同细胞和生理条件下培养的 Caco-2 细胞转录组的系统比较。
Arch Toxicol. 2023 Mar;97(3):737-753. doi: 10.1007/s00204-022-03430-y. Epub 2023 Jan 21.
9
From Qualitative to Quantitative AOP: A Case Study of Neurodegeneration.从定性到定量的不良结局途径:神经退行性变的案例研究
Front Toxicol. 2022 Mar 30;4:838729. doi: 10.3389/ftox.2022.838729. eCollection 2022.
10
Development of the SciRAP Approach for Evaluating the Reliability and Relevance of Toxicity Data.用于评估毒性数据可靠性和相关性的SciRAP方法的开发。
Front Toxicol. 2021 Oct 15;3:746430. doi: 10.3389/ftox.2021.746430. eCollection 2021.